MH Criqui, BA Golomb - The Lancet, 2008 - Elsevier Drug treatment for dyslipidaemia is a mainstay of clinical practice in developed
countries. Monitoring of lipid-lowering treatment contributes additionally to
the already substantial cost. 1 In the randomised LIPID trial (pravastatin ... Related articles - All 35 versions
Y Ben-Haim, M Zacksenhouse, C Keren, CC … - technion.ac.il Diagnosis and treatment is a complex interaction of subjective information and
impressions, objective data, individual needs and preferences, and resource
constraints. The interpretation of quantitative information relies on ... Related articles - View as HTML - All 5 versions
[CITATION] Last literature review for version 16.3: Wed Oct 01 00: 00: 00 GMT 2008| This topic last …
AI Med - Ann Intern Med, 2008 - Am Coll Physicians While clinical inertia can be a pejorative term, acknowledging our own
deficiencies (1) was a key first step in improving our care (2). Requiring that
every detail of recommendations for care be based on evidence from clinical ...
Y Ben-Haim, M Zacksenhouse, C Keren, CC … - Medical Hypotheses, 2009 - Elsevier The diagnosis of diabetes, based on measured fasting plasma glucose level,
depends on choosing a threshold level for which the probability of failing to
detect disease (missed diagnosis), as well as the probability of falsely ... Related articles - All 49 versions
C Activities, N Medicines, NPCT Network - MeReC Bulletin, 2009 - npc.co.uk ICSs are safe and effective for most patients with asthma, although the risk of
systemic side effects is greater when higher doses are used. The dose of ICS
should be titrated to the lowest dose at which effective control of asthma ... Related articles - Cached - All 2 versions